Nurse Practitioner, Adult Health · Miami, FL
NPI
1982144028
Since 2017
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
13212 SW 39th Ter
Miami, FL, 33175
Phone (786) 213-3187
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$215K
21,337 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Irma Y Tauler prescribed most often to Medicare patients was Sertraline Hcl, with 3,114 prescriptions and refills. In total Irma Y Tauler wrote 21,337 Medicare prescriptions that cost $215K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-07.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Sertraline Hcl Generic | 3,114 | 3,123 | 397 | $8,038 |
| Escitalopram Oxalate Generic | 2,664 | 2,678 | 362 | $8,014 |
| Trazodone Hcl Generic | 1,712 | 1,738 | 249 | $3,238 |
| Buspirone Hcl Generic | 1,579 | 1,586 | 235 | $4,060 |
| Mirtazapine Generic | 1,486 | 1,488 | 211 | $15K |
| Memantine Hcl Generic | 1,326 | 1,337 | 215 | $18K |
| Citalopram Hbr Citalopram Hydrobromide | 1,085 | 1,085 | 155 | $1,448 |
| Quetiapine Fumarate Generic | 1,010 | 1,017 | 127 | $8,924 |
| Alprazolam Generic | 977 | 977 | 137 | $1,297 |
| Duloxetine Hcl Generic | 938 | 958 | 120 | $20K |
| Clonazepam Generic | 827 | 827 | 105 | $8,075 |
| Donepezil Hcl Generic | 628 | 630 | 95 | $1,088 |
| Chlordiazepoxide Hcl Generic | 611 | 611 | 89 | $3,995 |
| Temazepam Generic | 550 | 550 | 74 | $5,557 |
| Bupropion Hcl Generic | 389 | 389 | 59 | $5,129 |
Brand drugs: 95 claims; generic drugs: 21,242 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Irma Y Tauler were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.